Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-09-11T02:44:41.735Z.
Calculation as of: 2026-09-11T02:44:41.735Z.
Quote observation: 2026-09-10T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d670d92a9ed985c4ba88d5830250f1e4eb43691fb1e0723b4e8904464d1c2daf
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
Market Cap
$10.45B
EBITDA Yield
4.92%
TTM Avg
13.37%
3Y Avg
12.05%
5Y Avg
10.48%
Market Cap
$10.46B
EBITDA Yield
17.33%
TTM Avg
15.27%
3Y Avg
12.85%
5Y Avg
12.62%
Market Cap
$10.07B
EBITDA Yield
4.83%
TTM Avg
4.16%
3Y Avg
4.24%
5Y Avg
4.76%
Market Cap
$10.56B
EBITDA Yield
N/A
TTM Avg
6.22%
3Y Avg
5.39%
5Y Avg
4.89%
Market Cap
$9.93B
EBITDA Yield
3.60%
TTM Avg
4.65%
3Y Avg
5.15%
5Y Avg
4.77%
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tempus AI, Inc. (TEM) | $10.29B | N/A | N/A | N/A | N/A |
| Molina Healthcare, Inc. (MOH)vs › | $10.45B | 4.92% | 13.37% | 12.05% | 10.48% |
| Universal Health Services, Inc. (UHS)vs › | $10.46B | 17.33% | 15.27% | 12.85% | 12.62% |
| The Ensign Group, Inc. (ENSG)vs › | $10.07B | 4.83% | 4.16% | 4.24% | 4.76% |
| The Cooper Companies, Inc. (COO)vs › | $10.56B | N/A | 6.22% | 5.39% | 4.89% |
| Henry Schein, Inc. (HSIC)vs › | $9.94B | 7.99% | 8.58% | 8.46% | 8.63% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.93B | 3.60% | 4.65% | 5.15% | 4.77% |
| Globus Medical, Inc. (GMED)vs › | $9.92B | 9.80% | 6.78% | 5.15% | 4.79% |
| Align Technology, Inc. (ALGN)vs › | $10.79B | N/A | 7.28% | 5.51% | 4.81% |
| Insulet Corp. (PODD)vs › | $9.33B | 6.38% | 3.75% | 2.51% | 1.81% |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
